Target intelligence / Profile preview

Redox-sensitive cysteine residues

Molecular classification
Protein residues, Post-translational modification sites, Redox sensors
01

Overview

Redox-sensitive cysteine residues are highly reactive thiol-containing amino acids that serve as critical sensors and regulators of cellular signaling and oxidative stress. These residues possess a lower pKa than typical cysteines, allowing them to exist as nucleophilic thiolate anions at physiological pH, which makes them susceptible to modifications such as sulfenylation, nitrosylation, and covalent bonding with electrophilic molecules (PMID: 21810451). In drug discovery, these residues are targeted by electrophilic small molecules, known as covalent inhibitors, to achieve potent and prolonged modulation of therapeutic targets like Bruton's tyrosine kinase (BTK) and the epidermal growth factor receptor (EGFR) (PMID: 26030318). For instance, dimethyl fumarate targets specific cysteines on the KEAP1 protein to activate the Nrf2 antioxidant response, providing neuroprotective and anti-inflammatory effects in multiple sclerosis (PMID: 23515050). While targeting these residues offers advantages in potency and selectivity, it also carries risks of off-target reactivity and the formation of haptens, which can trigger immune-mediated adverse reactions. Consequently, the development of drugs targeting these residues requires careful optimization of electrophilicity to balance reactivity with target specificity.

Other names
Reactive cysteinesNucleophilic cysteinesThiol switchesElectrophile-responsive elementsCysteine-based redox sensors
02

Mechanism of action

Covalent modification of nucleophilic cysteine thiol groups via Michael addition or nucleophilic substitution, leading to irreversible or slowly reversible protein inhibition or activation.

03

Biological functions

Redox signalingOxidative stress responseSignal transductionEnzymatic regulationProtein homeostasis
04

Disease associations

CancerInflammationNeurodegenerative diseaseAutoimmune diseaseCardiovascular disease
05

Safety considerations

Off-target covalent modification of non-target proteinsHapten formation leading to immune-mediated hypersensitivityDepletion of cellular glutathionePotential for idiosyncratic drug toxicity
06

Interacting drugs

Ibrutinib

6 more in the full profile.

07

Biomarkers

Glutathione (GSH) levelsNrf2-target gene expression (e.g., NQO1, HMOX1)Protein-drug covalent adductsReactive oxygen species (ROS) levels

Beyond the preview

Go deeper on Redox-sensitive cysteine residues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Redox-sensitive cysteine residues.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call